Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Indivior Pharmaceuticals (INDV) Current Leases (2021 - 2025)

Indivior Pharmaceuticals (INDV) has 4 years of Current Leases data on record, last reported at $10.0 million in Q4 2025.

  • For Q4 2025, Current Leases changed 0.0% year-over-year to $10.0 million; the TTM value through Dec 2025 reached $10.0 million, changed 0.0%, while the annual FY2025 figure was $10.0 million, 0.0% changed from the prior year.
  • Current Leases reached $10.0 million in Q4 2025 per INDV's latest filing, roughly flat from $10.0 million in the prior quarter.
  • Across five years, Current Leases topped out at $11.0 million in Q1 2025 and bottomed at $8.0 million in Q4 2021.
  • Average Current Leases over 4 years is $9.9 million, with a median of $10.0 million recorded in 2024.
  • Peak YoY movement for Current Leases: grew 11.11% in 2024, then changed 0.0% in 2025.
  • A 4-year view of Current Leases shows it stood at $8.0 million in 2021, then rose by 12.5% to $9.0 million in 2023, then grew by 11.11% to $10.0 million in 2024, then changed by 0.0% to $10.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Leases were $10.0 million in Q4 2025, $10.0 million in Q3 2025, and $11.0 million in Q2 2025.